ANI pharma acquires 22 generic drug from Teva

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2015

Singapore: US based ANI Pharmaceuticals has acquired 22 previously marketed generic drug products from Teva Pharmaceutic...Read more

Patents rights in India unreasonably denied: US Pharma

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2013

Singapore: Expressing grave concern over the deteriorating intellectual property environment in India, the Pharmaceutica...Read more

Sun Pharma cancer drug to address shortage

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

Singapore: The US Food and Drug Administration has approved the first generic version of the cancer drug Doxil (doxorubi...Read more

Prasco Lab to market generics version of Colcrys in US

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jan, 2015

Singapore: US generics firm, Prasco Laboratories, has entered into alliance with US subisdiary of Japanese pharmaceutica...Read more

Jubilant smoking cessation aid gets FDA nod

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Oct, 2013

Singapore: India's leading pharma company, Jubilant Life Sciences received an approval from the US FDA for its anti-depr...Read more

Aussie's IDT to manufacture 23 generic drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Apr, 2015

Singapore: US FDA has accepted the transfer of ownership of 23 generic drug products to Australia based IDT. Formalising...Read more

Novartis case hearing against Indian patent office on Sept 11

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2012

Bangalore: The Supreme Court will take up the landmark case involving swiss drugmaker Novartis and India's patent office...Read more

Generics will lead to $7 bn loss for statins market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jan, 2013

Singapore: GBI Research has highlighted that the introduction of generic statins has kick started a decline in the globa...Read more

Sun Pharma's founder named India's 3rd richest

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Oct, 2013

Singapore: For the first time, founder of leading Indian drugmaker Sun Pharmaceuticals, Mr Dilip Shanghvi has been named...Read more

Mylan launches generic of Pfizer's antifungal drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

Singapore: US-based Mylan Pharmaceuticals has launched generic version of Pfizer's Vfend, Voriconazole for Oral Suspensi...Read more

Cipla wins patent case against Roche

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

Bangalore: India's generics giant Cipla has won a landmark patent case against Swiss drug maker Roche in the Delhi High ...Read more

Sun Pharma registers Rs 1391 crores profit in Q1

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2014

Singapore: Posting a net profit of Rs 1391 crores in Q1, Sun Pharma exhibited a flat growth in line with the market expe...Read more

Teva patent request rejected by US Supreme Court

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Nov, 2013

Singapore: The US Supreme Court declined a request from Teva Pharmaceutical for a stay of an appeals court ruling that w...Read more

Daiichi Sankyo seeks approval for TB drug in Japan

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Oct, 2014

Singapore: Daiichi Sankyo's generic subsidiary, Daiichi Sankyo Espha has submitted a supplemental New Drug Application (...Read more

Aurobindo to acquire Actavis generics unit in EU

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jan, 2014

Mumbai: India-based Aurobindo Pharma intends to acquire Actavis' generics commercial operations in seven markets in West...Read more

Ranbaxy sues Actavis to stop acne generic sale

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Nov, 2013

Singapore: Dublin headquartered generic drugmaker Actavis has now been caught in a legal tangle after Indian drug major ...Read more

IPAB revokes patent for GSK's anti-cancer drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

New Delhi: In yet another blow to multinational companies operating in India, the Intellectual Property Appellate Board ...Read more

TWi appoints new CEO to boost US market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Mar, 2015

Singapore: Taiwan based TWi Pharmaceuticals has appointed Ms Tina Guilder as President and CEO and Ms Eva Ho as CFO to s...Read more